BioSpace News Archive

Aerie Pharmaceuticals, Inc. today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a fireside discussion at the Stifel 2018 Healthcare Conference on Tuesday, November 13, 2018 at 10:15 a.m. Eastern Time in New York, NY.

XableCath, a commercial-stage medical device company, announced today that it has demonstrated initial safety and efficacy of its unique catheters for use with chronic venous occlusions, commonly characterized by recalcitrant lesions that have historically proven difficult to cross with standard catheter technologies.

Quarterly Net Sales Increased 20 Percent to $325.3 Million, a Record for the Company; Third-Quarter 2018 GAAP Net Income of $26.0 Million; Adjusted EBITDA of $149.9 Million

OncoSec Medical Incorporated (OncoSec) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced that the first patient has been treated in KEYNOTE-890, a Phase 2 clinical trial for the treatment of late-stage triple negative breast cancer (TNBC) with TAVO

The Company expects all operations and relationships to continue without interruption through this transition.

Force Therapeutics, a leader in episode-based digital care delivery, today announced a $21 million funding round led by Insight Venture Partners, a New York-based venture capital and private equity firm

Audentes Therapeutics, Inc. today announced that it will participate in the following investor conferences in November:

Biorem’s complete third quarter financial statements and MD&A have been filed on SEDAR

EVIO Inc. announced that EVIO Canada’s Keystone Labs in Edmonton is ready to prosper and service the Canadian cannabis legalization market.

Rêveur Corporation recorded $1,171,389 (USD$900,376) in revenue from its Adelanto operations.